ArticleClinical and vaccine immunology : CVI2015

Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky.

Yehuda L Danon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.